Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1972 1
1973 1
1974 1
1975 3
1976 2
1977 2
1979 2
1985 1
1986 1
1987 2
1988 4
1989 4
1990 5
1991 1
1995 1
2001 2
2002 3
2003 5
2004 10
2005 9
2006 5
2007 8
2008 3
2009 8
2010 13
2011 14
2012 18
2013 24
2014 32
2015 42
2016 51
2017 44
2018 31
2019 25
2020 35
2021 40
2022 39
2023 57
2024 57

Text availability

Article attribute

Article type

Publication date

Search Results

521 results

Results by year

Filters applied: . Clear all
Page 1
Thrombus or tumor?
Wakasa S, Hayashi H, Yamazaki T, Izumiya Y, Fukuda D. Wakasa S, et al. Among authors: fukuda d. Clin Case Rep. 2023 Sep 28;11(10):e7975. doi: 10.1002/ccr3.7975. eCollection 2023 Oct. Clin Case Rep. 2023. PMID: 37780915 Free PMC article.
STING, a cytosolic DNA sensor, plays a critical role in atherogenesis: a link between innate immunity and chronic inflammation caused by lifestyle-related diseases.
Pham PT, Fukuda D, Nishimoto S, Kim-Kaneyama JR, Lei XF, Takahashi Y, Sato T, Tanaka K, Suto K, Kawabata Y, Yamaguchi K, Yagi S, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Shimada K, Kanematsu Y, Takagi Y, Shimabukuro M, Setou M, Barber GN, Sata M. Pham PT, et al. Among authors: fukuda d. Eur Heart J. 2021 Nov 7;42(42):4336-4348. doi: 10.1093/eurheartj/ehab249. Eur Heart J. 2021. PMID: 34226923
Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR).
Tanaka A, Shibata H, Imai T, Yoshida H, Miyazono M, Takahashi N, Fukuda D, Okada Y, Teragawa H, Suwa S, Kida K, Moroi M, Taguchi I, Toyoda S, Shimabukuro M, Tanabe K, Tanaka K, Nangaku M, Node K; FIVE-STAR trial investigators. Tanaka A, et al. Among authors: fukuda d. Cardiovasc Diabetol. 2023 Jul 31;22(1):194. doi: 10.1186/s12933-023-01928-y. Cardiovasc Diabetol. 2023. PMID: 37525257 Free PMC article. Clinical Trial.
521 results